Arkadios Wealth Advisors Moderna, Inc. Transaction History

Arkadios Wealth Advisors

$1.64 Billion
Q3 2024

A detailed history of Arkadios Wealth Advisors transactions in Moderna, Inc. stock. As of the latest transaction made, Arkadios Wealth Advisors holds 11,429 shares of MRNA stock, worth $460,245. This represents 0.05% of its overall portfolio holdings.

Number of Shares

11,429

Previous 11,186 2.17%

Holding current value

$460,245

Previous $1.33 Million 42.55%

% of portfolio

0.05%

Previous 0.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$63.64 - $125.14 $15,464 - $30,409	243 Added 2.17%	11,429 $763,000
Q2 2024 Jul 29, 2024	BUY	$101.21 - $166.61 $28,541 - $46,984	282 Added 2.59%	11,186 $1.33 Million
Q1 2024 Apr 30, 2024	SELL	$85.37 - $115.44 $71,198 - $96,276	-834 Reduced 7.11%	10,904 $1.16 Million
Q4 2023 Jan 24, 2024	SELL	$69.51 - $104.43 $52,202 - $78,426	-751 Reduced 6.01%	11,738 $1.17 Million
Q3 2023 Oct 13, 2023	BUY	$96.41 - $126.61 $8,291 - $10,888	86 Added 0.69%	12,489 $1.29 Million
Q2 2023 Jul 26, 2023	SELL	$118.5 - $160.53 $97,407 - $131,955	-822 Reduced 6.22%	12,403 $1.51 Million
Q1 2023 May 02, 2023	SELL	$135.66 - $197.02 $13,837 - $20,096	-102 Reduced 0.77%	13,225 $2.03 Million
Q4 2022 Jan 11, 2023	SELL	$118.38 - $210.04 $5,919 - $10,502	-50 Reduced 0.37%	13,327 $0
Q3 2022 Oct 21, 2022	BUY	$118.07 - $194.18 $41,324 - $67,963	350 Added 2.69%	13,377 $1.58 Million
Q2 2022 Jul 14, 2022	BUY	$117.13 - $176.59 $1,171 - $1,765	10 Added 0.08%	13,027 $1.86 Million
Q1 2022 May 02, 2022	BUY	$126.46 - $235.05 $115,205 - $214,130	911 Added 7.53%	13,017 $2.24 Million
Q4 2021 Feb 03, 2022	BUY	$225.82 - $368.51 $69,778 - $113,869	309 Added 2.62%	12,106 $3.08 Million
Q3 2021 Oct 19, 2021	BUY	$221.9 - $484.47 $59,913 - $130,806	270 Added 2.34%	11,797 $4.54 Million
Q2 2021 Jul 28, 2021	BUY	$129.91 - $234.98 $33,776 - $61,094	260 Added 2.31%	11,527 $2.71 Million
Q1 2021 Apr 26, 2021	BUY	$109.18 - $185.98 $407,787 - $694,635	3,735 Added 49.59%	11,267 $1.48 Million
Q4 2020 Feb 09, 2021	BUY	$65.74 - $169.86 $65,477 - $169,180	996 Added 15.24%	7,532 $786,000
Q3 2020 Nov 10, 2020	BUY	$54.34 - $94.85 $145,957 - $254,767	2,686 Added 69.77%	6,536 $483 Million
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $25,219 - $68,000	850 Added 28.33%	3,850 $289 Million
Q1 2020 May 14, 2020	BUY	$17.78 - $31.58 $53,340 - $94,740	3,000 New	3,000 $89.9 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Arkadios Wealth Advisors with notifications on news.

Account

Arkadios Wealth Advisors Moderna, Inc. Transaction History